Craig-Hallum initiated coverage on Oklo (NYSE: OKLO) with a Buy rating and a set price target of $44.00. Currently trading at ...

As previously reported, Craig-Hallum initiated coverage of Oklo (OKLO) with a Buy rating and $44 price target The firm sees a path to $80-plus ...

Craig-Hallum notes that General Motors (GM) reported its Q4 numbers and provided an outlook for 2025. Part of GM’s outlook included an ...

Evolv Technologies Holdings Inc (EVLV) stock saw a decline, ending the day at $4.01 which represents a decrease of $-0.15 or -3.61% from the prior close of $4.16. The stock opened at $4.08 and touched ...

Craig-Hallum analyst Jeremy Hamblin raised the firm’s price target on Red Robin (RRGB) to $10 from $8.50 and keeps a Buy ...

Fintel reports that on January 21, 2025, Craig-Hallum initiated coverage of Core Scientific, Inc. - Equity Right (OTCPK:CORZR ...

On Monday, Cerence Inc (CRNC) stock saw a decline, ending the day at $13.1 which represents a decrease of $-0.94 or -6.70% from the prior close of $14.04. The stock opened at $13.1 and touched a low ...

Agilysys (NASDAQ:AGYS – Get Free Report) had its price target cut by stock analysts at Craig Hallum from $125.00 to $120.00 ...

Craig-Hallum analyst Chase Knickerbocker raised the firm’s price target on Eton Pharmaceuticals (ETON) to $23 from $18 and keeps a Buy rating on the shares. The firm is updating its model following ...

As previously reported, Craig-Hallum upgraded Rimini Street (RMNI) to Buy from Hold with a price target of $6, up from $2. The firm says that in “a stunningly decisive manner,” the Appeals ...

Craig Hallum assumed coverage on shares of Core Scientific (NASDAQ:CORZ – Free Report) in a report released on Tuesday ...

As previously reported, Craig-Hallum initiated coverage of Biote (BTMD) with a Buy rating and $12 price target Consumer interest in next-gen therapies like hormone replacement therapy, or HRT ...